Cetuximab (Erbitux) in Combination With Cisplatin or Carboplatin and 5-Fluorouracil in the First Line Treatment of Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (EXTREME)
Clinical trial NCT00122460 · COMPLETED
Trial details
- NCT number
- NCT00122460
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-12-01
- Primary completion
- 2007-03-01
- Enrollment
- 442
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.